Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 20.
Article
Allum, WH;
Smyth, EC;
Blazeby, JM;
Grabsch, HI;
Griffin, SM;
Rowley, S;
Cafferty, FH;
... Cunningham, D; + view all
(2019)
Quality assurance of surgery in the randomized ST03 trial of perioperative chemotherapy in carcinoma of the stomach and gastro‐oesophageal junction.
BJS
, 106
(9)
pp. 1204-1215.
10.1002/bjs.11184.
|
 |
|
Beyer, J;
Collette, L;
Sauvé, N;
Daugaard, G;
Feldman, DR;
Tandstad, T;
Tryakin, A;
... International Germ Cell Cancer Classification Update Consortium; + view all
(2021)
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium.
Journal of Clinical Oncology
, 39
(14)
pp. 1553-1562.
10.1200/JCO.20.03292.
|
|
|
Cafferty, F;
Coyle, C;
Rowley, S;
Berkman, L;
MacKensie, M;
Langley, RE;
(2017)
Co-enrolment of participants into multiple cancer trials: benefits and challenges.
Clinical Oncology
, 29
(7)
e126-e133.
10.1016/j.clon.2017.02.014.
|
|
|
Cafferty, FH;
Langley, RE;
(2017)
Whatever happened to the polypill? Polypill is not just for cardiovascular disease.
[Letter].
BMJ
, 357
, Article j2733. 10.1136/bmj.j2733.
|
|
Cafferty, FH;
White, JD;
Shamash, J;
Hennig, I;
Stenning, SP;
Huddart, RA;
TE23 Trial Management Group and Collaborators, .;
(2020)
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604).
European Journal of Cancer Care
, 127
pp. 139-149.
10.1016/j.ejca.2019.12.028.
|
|
|
Coyle, C;
Cafferty, FH;
Langley, RE;
(2016)
Aspirin and Colorectal Cancer Prevention and Treatment: Is It for Everyone?
Current Colorectal Cancer Reports
, 12
(1)
pp. 27-34.
10.1007/s11888-016-0306-9.
|
|
|
Coyle, C;
Cafferty, FH;
Rowley, S;
MacKenzie, M;
Berkman, L;
Gupta, S;
Pramesh, CS;
... Langley, RE; + view all
(2016)
ADD-ASPIRIN: A phase III, double-blind, placebo controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours.
Contemporary Clinical Trials
, 51
pp. 56-64.
10.1016/j.cct.2016.10.004.
|
|
Coyle, C;
Cafferty, FH;
Vale, C;
Langley, RE;
(2016)
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis.
Annals of Oncology
, 27
(12)
pp. 2184-2195.
10.1093/annonc/mdw410.
|
|
Cragg, WJ;
Cafferty, F;
Diaz-Montana, C;
James, EC;
Joffe, J;
Mascarenhas, M;
Yorke-Edwards, V;
(2019)
Early warnings and repayment plans: novel trial management methods for monitoring and managing data return rates in a multi-centre phase III randomised controlled trial with paper Case Report Forms.
Trials
, 20
(1)
, Article 241. 10.1186/s13063-019-3343-2.
|
|
Gilbert, DC;
Duong, T;
Kynaston, HG;
Alhasso, AA;
Cafferty, FH;
Rosen, SD;
Kanaga-Sundaram, S;
... Abel, PD; + view all
(2017)
Quality of life outcomes from the PATCH trial evaluating LHRH agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer.
BJU International
, 119
(5)
pp. 667-675.
10.1111/bju.13687.
|
|
Gillessen, S;
Sauvé, N;
Collette, L;
Daugaard, G;
de Wit, R;
Albany, C;
Tryakin, A;
... International Germ Cell Cancer Classification Update Consortium, .; + view all
(2021)
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium.
Journal of Clinical Oncology
, Article JCO2003296. 10.1200/JCO.20.03296.
(In press).
|
|
|
Huddart, RA;
Gabe, R;
Cafferty, FH;
Pollock, P;
White, JD;
Shamash, J;
Cullen, MH;
... National Cancer Research Institute Testis Cancer Clinical Studies Group, .; + view all
(2015)
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604).
Eur Urol
, 67
(3)
534 - 543.
10.1016/j.eururo.2014.06.034.
|
 |
|
Joffe, Johnathan K;
Cafferty, Fay H;
Murphy, Laura;
Rustin, Gordon JS;
Sohaib, Syed A;
Gabe, Rhian;
Stenning, Sally P;
... TRISST Trial Management Group and Investigators, .; + view all
(2022)
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST).
Journal of Clinical Oncology
, 40
(22)
pp. 2468-2478.
10.1200/JCO.21.01199.
|
|
Joharatnam-Hogan, N;
Alexandre, L;
Yarmolinsky, J;
Lake, B;
Capps, N;
Martin, RM;
Ring, A;
... Langley, RE; + view all
(2021)
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs.
Current Oncology Reports
, 23
, Article 29. 10.1007/s11912-021-01023-z.
|
|
|
Joharatnam-Hogan, N;
Cafferty, F;
Hubner, R;
Swinson, D;
Sothi, S;
Gupta, K;
Falk, S;
... Add-Aspirin Trial Management Group; + view all
(2019)
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
The Lancet Gastroenterology & Hepatology
, 4
(11)
pp. 854-862.
10.1016/S2468-1253(19)30289-4.
|
|
Joharatnam-Hogan, N;
Cafferty, FH;
Macnair, A;
Ring, A;
Langley, RE;
(2020)
The role of aspirin in the prevention of ovarian, endometrial and cervical cancers.
Women's Health
, 16
10.1177/1745506520961710.
|
|
|
Langley, RE;
Kynaston, HG;
Alhasso, AA;
Duong, T;
Paez, EM;
Jovic, G;
Scrase, CD;
... Abel, PD; + view all
(2016)
A Randomised Comparison Evaluating Changes in Bone Mineral Density in Advanced Prostate Cancer: Luteinising Hormone-releasing Hormone Agonists Versus Transdermal Oestradiol.
European Urology
, 69
(6)
pp. 1016-1025.
10.1016/j.eururo.2015.11.030.
|
|
Macnair, A;
Love, SB;
Murray, ML;
Gilbert, DC;
Parmar, MKB;
Denwood, T;
Carpenter, J;
... Cafferty, FH; + view all
(2021)
Accessing routinely collected health data to improve clinical trials: recent experience of access.
Trials
, 22
, Article 340. 10.1186/s13063-021-05295-5.
|
|
|
Parmar, MK;
Cafferty, FH;
Sydes, MR;
Choodari-Oskooei, B;
Langley, RE;
Brown, L;
Phillips, PP;
... Royston, PJ; + view all
(2017)
Testing many treatments within a single protocol over 10 years at MRC Clinical Trials Unit at UCL: Multi-arm, multi-stage platform, umbrella and basket protocols.
Clinical Trials
, 14
(5)
pp. 451-461.
10.1177/1740774517725697.
|
|
|
Smyth, EC;
Rowley, S;
Cafferty, FH;
Allum, W;
Grabsch, HI;
Stenning, S;
Wotherspoon, A;
... Cunningham, D; + view all
(2019)
Safety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial.
JAMA Oncology
, 5
(8)
pp. 1181-1187.
10.1001/jamaoncol.2019.1179.
|
|
